Investigation of genetic factors in primary ovarian insufficiency
Official title: Insight Into the Genomics of Idiopathic Premature Ovarian Insufficiency
Run by Ospedale Policlinico San Martino · NCT05327283 · Data updated 2026-11-12
This study is trying to find out if certain genes play a role in primary ovarian insufficiency in women diagnosed before age 38, to improve future testing and treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 15 Years to 38 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Ospedale Policlinico San Martino Academic / other |
| Locations | 1 site (Genova) |
| Status | Recruiting |
| Started | January 31, 2012 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | April 25, 2022 |
| Trial ID | NCT05327283 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women diagnosed with primary ovarian insufficiency before the age of 38 who exhibit specific markers of diminished ovarian reserve.
✕Probably not a fit
Patients with POI related to conditions such as previous ovarian surgery, chemotherapy, or known autoimmune diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the genetic underpinnings of primary ovarian insufficiency (POI), a condition characterized by the premature depletion of ovarian follicles. By utilizing advanced genome-wide strategies such as high-resolution array-CGH and whole exome sequencing (WES), the researchers seek to identify genetic variants that contribute to the heterogeneity of POI. The study focuses on women diagnosed with POI before the age of 38, examining various markers of ovarian reserve to better understand the condition's biological mechanisms. The ultimate goal is to enhance testing and treatment strategies for affected women in the future.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and therapeutic options for women suffering from primary ovarian insufficiency.
How similar studies have gone: While there have been studies investigating genetic factors in POI, this approach utilizing genome-wide strategies is relatively novel and aims to address unexplained aspects of the condition.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age at diagnosis \<38 years; * a normal 46,XX karyotype (no FRM1 premutation); * at least one marker of ovarian reserve not age-appropriate: * baseline FSH levels \> cut-off \[1\] and/or * age-specific AMH \< cut-off \[2\] and/or * AFC \< 5; and/or * cancellation of a PMA cycle because of poor response (\<3 follicles) to high-dose gonadotrophins (250 U/die) and/or * retrieval of \< 4 oocytes in response to high-dose stimulation protocols (3000 U of gonadotrophins). Exclusion Criteria: * patients with POI-related conditions, such as ovarian surgery or previous chemo- or radio-therapy; endometriosis or known autoimmune or metabolic diseases.
Where it's running
-
UOS Fisiopatologia della Riuproduzione Umana
Genova, Italy Recruiting
Study contacts
- Principal investigator: Paola Scaruffi — Ospedale San Martino
- Study coordinator: Paola Scaruffi, PhD
- Email: paola.scaruffi@hsanmartino.it
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Identifying genetic variants in non-obstructive azoospermia and primary ovarian insufficiency
This project will collect DNA from adults with NOA, oligospermia, or POI to try to find gene changes that may cause their infertility.
-
Estrogen therapy and heart health in women with POI
This study tests whether starting estrogen replacement helps heart-health markers in women newly diagnosed with POI compared with healthy peers.
-
Comparing progesterone options for endometrial protection in young women on estrogen therapy
This study is testing whether oral progesterone or a hormone implant is better at protecting the uterus in young women who are taking estrogen therapy.
-
Investigating mitochondrial dysfunction in women with PCOS and infertility
This study is trying to see if problems with energy production in cells are linked to polycystic ovary syndrome (PCOS) and infertility in women.
-
Autologous Hair Follicle Secretome + PRP for POI
This pilot study tests whether a patient’s own hair follicle secretome combined with their own platelet-rich plasma can improve ovarian function in women with premature ovarian insufficiency.
-
Bleeding patterns with sequential versus continuous progesterone in adolescents with Turner syndrome
This study will test whether taking progesterone continuously or in a sequential (monthly) schedule changes bleeding patterns in adolescents with Turner syndrome who are on estrogen replacement therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.